XPREZA 200MG TABLET

Form: Tablets

Pack Size: 14 TABLETS

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹11499.46

NATCO PHARMA LTD (ONCOLOGY DIV): Xpreza 200MG Tablet, 14 tablets, salt azacitidine 200mg. NPPA has revised its MRP from Rs 15,000 to Rs 11,499.46 (23% lower) with effect from 09-11-2026; trade rate Rs 8,761.49. Group: hypomethylating agent (chemotherapy). Same salt is also supplied by Hetero, MSN. Handling/counselling: injection and tablet forms are not interchangeable; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.